The Pharmaceutical companies Pfizer and BioNTech who are developing the Covid Vaccines have asked the United States to extend the vaccinations to the children as well.
Pfizer Releases Data For Effective Vaccinations Towards Younger Group
As per the latest reports, both Pfizer and BioNTech have approached the US Food and Drug Administration (FDA) to expand the Emergency Use Authorization (EUA) to the younger group as well. They have asked them to extend the vaccines to the age groups of 12 to 15 years of age.
This comes after Pfizer released data which said that the vaccine was 100 percent effective and the younger group has responded well to the vaccines as well. Recently, Pfizer released data from a clinical trial showing that the drug is 100 percent effective and have studied the case of 1,131 adolescents who received the vaccine instead of placebo.
Study Suggests Milder Dose For Younger Children
The ongoing studies so far suggests that the children younger than 12 years of age need a milder dose of the Covid vaccine. However, the ones which fall from 12-15 years of age can have the same dose as adults who receive the Pfizer vaccine.
ALSO READ:-Pfizer Vaccine Data Hacked from European Medicines Agency
The findings also include that the children have stronger overall immunity responses for one month after the second dose of the vaccine. Albert Bourla, The Chairman and the Chief Executive Officer at Pfizer said that they understand the urgency of the circumstances and want to start the vaccinations for the younger population as well. The same is encouraged by their clinical trials as well.
Even though Pfizer-BioNTech Vaccines have not been approved or licensed by FDA but they are being used for emergencies. As of now, netizens have 16 years of age are eligible to take the Covid 19 vaccine jabs.
As per reports, 68.2 million people in the US have already been fully vaccinated.
